DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway
AbstractPurpose Hepatocellular carcinoma (HCC) is refractory cancer with high morbidity and high mortality. DEAH-box polypeptide 32 (DHX32) was upregulated in several types of malignancies and predicted poor prognosis. Herein, we investigated the role of DHX32 in HCC progression.Methods The expressi...
Auteurs principaux: | , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Taylor & Francis Group
2021-01-01
|
Collection: | Annals of Medicine |
Sujets: | |
Accès en ligne: | https://www.tandfonline.com/doi/10.1080/07853890.2021.1898674 |